Abstract
Zonisamide (ZNS), a sulfonamide antiepileptic drug, is indicated as an adjunct therapy for partial seizure disorders with and without secondary generalization. ZNS has a favorable pharmacokinetic profile because of its rapid absorption and high bioavailability. Its activity is related to the blockade of voltage gated sodium and calcium channels, modulation of central dopaminergic, GABAergic, and serotonergic functions, as well as inhibition of carbonic anhydrase and monoamine oxidase B. ZNS has potential efficacy for an array of neuropsychiatric disorders including migraine and other headache syndromes, neuropathic pain, Parkinsons disease, essential tremor, stroke, obesity, anxiety, bipolar and bingeeating disorders.
Keywords: zonisamide, seizure disorders, migraine, pain syndromes, movement disorders, neuroprotection, bipolar and anxiety disorders
Mini-Reviews in Medicinal Chemistry
Title: Therapeutic Role of Zonisamide in Neuropsychiatric Disorders
Volume: 8 Issue: 10
Author(s): Muhammad U. Farooq, Philip W. Moore, Archit Bhatt, Rany Aburashed and Mounzer Y. Kassab
Affiliation:
Keywords: zonisamide, seizure disorders, migraine, pain syndromes, movement disorders, neuroprotection, bipolar and anxiety disorders
Abstract: Zonisamide (ZNS), a sulfonamide antiepileptic drug, is indicated as an adjunct therapy for partial seizure disorders with and without secondary generalization. ZNS has a favorable pharmacokinetic profile because of its rapid absorption and high bioavailability. Its activity is related to the blockade of voltage gated sodium and calcium channels, modulation of central dopaminergic, GABAergic, and serotonergic functions, as well as inhibition of carbonic anhydrase and monoamine oxidase B. ZNS has potential efficacy for an array of neuropsychiatric disorders including migraine and other headache syndromes, neuropathic pain, Parkinsons disease, essential tremor, stroke, obesity, anxiety, bipolar and bingeeating disorders.
Export Options
About this article
Cite this article as:
Farooq U. Muhammad, Moore W. Philip, Bhatt Archit, Aburashed Rany and Kassab Y. Mounzer, Therapeutic Role of Zonisamide in Neuropsychiatric Disorders, Mini-Reviews in Medicinal Chemistry 2008; 8 (10) . https://dx.doi.org/10.2174/138955708785740643
DOI https://dx.doi.org/10.2174/138955708785740643 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
From Antidepressant Drugs to Beta-Mimetics: Preclinical Insights on Potential New Treatments for Neuropathic Pain
Recent Patents on CNS Drug Discovery (Discontinued) Dihydrocodeine as an Opioid Analgesic for the Treatment of Moderate to Severe Chronic Pain
Current Drug Metabolism MicroRNAs in CAG Trinucleotide Repeat Expansion Disorders: an Integrated Review of the Literature
CNS & Neurological Disorders - Drug Targets Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism
Recent Patents on CNS Drug Discovery (Discontinued) Gene Therapy for Parkinsons Disease: Progress and Challenges
Current Gene Therapy Approaching Neurological Diseases to Reduce Mobility Limitations in Older Persons
Current Pharmaceutical Design Overview and Findings from the Religious Orders Study
Current Alzheimer Research Tremor and Rigidity in Patients with Parkinson’s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors
CNS & Neurological Disorders - Drug Targets Abuse of Clenbuterol and its Detection
Current Medicinal Chemistry An Update on Clinical Drug Interactions with the Herbal Antidepressant St. Johns wort
Current Drug Metabolism Antiprotozoal Agents: An Overview
Anti-Infective Agents in Medicinal Chemistry A Review on Mouth Dissolving Films
Current Drug Delivery SPECT Radiopharmaceuticals for Dementia
Current Radiopharmaceuticals In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
Current Neuropharmacology Chemical Connexin Impairment in the Developing Gonad Associated with Offspring Infertility
Current Medicinal Chemistry Vitamin D: Preventive and Therapeutic Potential in Parkinson’s disease
Current Drug Metabolism Current Status of Tyrosine Hydroxylase in Management of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets GHB Pharmacology and Toxicology: Acute Intoxication, Concentrations in Blood and Urine in Forensic Cases and Treatment of the Withdrawal Syndrome
Current Neuropharmacology Herbals and Natural Dietary Supplements in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued) Phosphoproteomic Analysis of <i>Spiroplasma eriocheiris</i> and Crosstalk with Acetylome Reveals the Role of Post-Translational Modifications in Metabolism
Current Proteomics